LINC01705: A Potential Drug Target Or Biomarker (G107985307)

Target Name: LINC01705

NCBI ID: G107985307

LINC01705

Other Name(s): long intergenic non-protein coding RNA 1705 | Long intergenic non-protein coding RNA 1705

LINC01705: A Potential Drug Target Or Biomarker

LINC01705 is a long intergenic non-protein coding RNA (lncRNA) that has been identified as a potential drug target or biomarker. It is a non-coding RNA molecule that is expressed in a variety of tissues and cells throughout the body. LINC01705 has been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation.

One of the key features of LINC01705 is its length. It is approximately 290 nucleotides long, which makes it one of the longer lncRNAs that have been identified. The long length of LINC01705 may allow it to interact with other molecules in the cell in more complex ways and to play a more significant role in cellular processes.

In addition to its length, LINC01705 has other characteristics that make it a potential drug target or biomarker. For example, it is highly expressed in a variety of tissues, including the brain, heart, and liver. This suggests that it may be involved in the regulation of important cellular processes that are relevant to these tissues, making it a potential target for drugs that are designed to modulate these processes. Additionally, LINC01705 has been shown to play a role in the regulation of cellular apoptosis, which is the process by which cells die when they are no longer needed. This suggests that it may be a useful biomarker for assessing the effectiveness of drugs that are designed to induce or inhibit apoptosis.

Another potential mechanism by which LINC01705 may be involved in cellular processes is its role in the regulation of gene expression. LncRNAs are known to play a critical role in the regulation of gene expression, and LINC01705 is no exception. It has been shown to interact with a variety of transcription factors, including activator protein 1 (AP-1), which is a key regulator of cell growth and differentiation. This suggests that LINC01705 may be involved in the regulation of cellular processes that are controlled by these transcription factors.

In conclusion, LINC01705 is a long intergenic non-protein coding RNA that has been identified as a potential drug target or biomarker. Its long length and its role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation make it a promising candidate for further study. Further research is needed to determine the full extent of LINC01705's role in cellular processes and to explore its potential as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1705

The "LINC01705 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01705 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets